31P magnetic resonance spectroscopy after combined hyperthermia and radiation.
Mechanisms of uveal melanoma response to therapy are poorly understood. There are a paucity of changes that have been detected immediately after tumor treatment to differentiate successful from ineffective therapy. In this study we used in vivo 31P magnetic resonance spectroscopy (MRS) to assess intra-tumor treatment alterations. The metabolic consequences of effective and ineffective levels of solitary hyperthermia and combined hyperthermia-radiation were investigated. We have previously noted a characteristic 31P MRS pattern with successful hyperthermia in this intraocular melanoma model. The metabolic response after effective or ineffective combined radiation/hyperthermia therapy was indistinguishable from solitary radiation therapy and opposite to that with successful hyperthermia therapy. In contrast to solitary hyperthermia therapy, early changes in 31P spectral ratios following radiation or combined hyperthermia/radiation therapy of uveal melanoma were not predictive of treatment response. Twenty-four to 48 hours after effective or ineffective radiation or combined treatment the Pi/beta-NTP ratio decreased significantly (delta Pi/beta-NTP = -0.433 +/- 0.08 and -0.478 +/- .13 and .10 +/- 0.2, respectively). There was over a 2.0 thermal enhancement of radiation with heat. The increased tumor cell death after combined therapy was reflected by a two-fold larger decrease in beta-NTP signal-to-noise (S/N).
Kurhanewicz
J
J
Department of Ophthalmology, University of California, San Francisco.
Char
D H
DH
Stauffer
P
P
Quivey
J M
JM
James
T L
TL
D000818:Animals; D001918:Brachytherapy; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D006979:Hyperthermia, Induced; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000628:therapy*; D009368:Neoplasm Transplantation; D011817:Rabbits; D011877:Radionuclide Imaging; D014604:Uveal Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000628:therapy*
D007457:Iodine Radioisotopes